949: prognostic liver secretome signature and alpha-fetoprotein (plsec-afp) predicts long-term hepatocellular carcinoma risk in patients with cirrhosis: a nationwide phase 3 biomarker study in the u.s.
GASTROENTEROLOGY（2022）
关键词
prognostic liver secretome signature,hepatocellular carcinoma,cirrhosis,alpha-fetoprotein,plsec-afp,long-term
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要